Download PDF
Semin Reprod Med 2022; 40(01/02): e1-e8
DOI: 10.1055/s-0042-1757138
Review Article

Polycystic Ovary Syndrome in Adolescence

Anju E. Joham 
1   Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
2   Department of Diabetes and Vascular Medicine, Monash Health, Melbourne, Australia.
,
Alexia S. Peña
3   Discipline of Paediatrics, Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia
4   Department of Endocrinology and Diabetes, Women's and Children's Hospital, North Adelaide, South Australia, Australia
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Polycystic ovary syndrome (PCOS) is a common, complex, and chronic condition that presents many diagnostic and management challenges for managing clinicians. PCOS diagnosis in adolescents presents a particular challenge for treating clinicians due to the overlap of diagnostic features with normal physiological changes during adolescence. Adolescent diagnostic criteria include well-defined menstrual irregularity according to time postmenarche and hyperandrogenism, but does not require the use of pelvic ultrasound. Adolescents with only one criterion should be considered at risk of PCOS and be followed up around transition to adult care. While PCOS was traditionally considered to be a reproductive disorder, PCOS is now recognized to have major metabolic and cardiovascular health consequences and psychological sequelae that can be present from adolescence. Management of PCOS includes healthy lifestyle, metformin, combined oral contraceptive pill, and/or antiandrogens according to symptoms of concern even in adolescents at risk of PCOS.

Keywords

polycystic ovary syndrome - adolescents - diagnosis


Publication History

Article published online:
12 September 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2016; 31 (12) 2841-2855
    CrossrefPubMedGoogle Scholar
  • 2 Naz MSG, Tehrani FR, Majd HA. et al. The prevalence of polycystic ovary syndrome in adolescents: a systematic review and meta-analysis. Int J Reprod Biomed (Yazd) 2019; 17 (08) 533-542
    PubMedGoogle Scholar
  • 3 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19 (01) 41-47
    CrossrefPubMedGoogle Scholar
  • 4 Kakoly NS, Khomami MB, Joham AE. et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update 2018; 24 (04) 455-467
    CrossrefPubMedGoogle Scholar
  • 5 Kakoly NS, Earnest A, Teede HJ, Moran LJ, Joham AE. The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome. Diabetes Care 2019; 42 (04) 560-567
    CrossrefPubMedGoogle Scholar
  • 6 Joham AE, Teede HJ, Ranasinha S, Zoungas S, Boyle J. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J Womens Health (Larchmt) 2015; 24 (04) 299-307
    CrossrefPubMedGoogle Scholar
  • 7 Tay CT, Teede HJ, Hill B, Loxton D, Joham AE. Increased prevalence of eating disorders, low self-esteem, and psychological distress in women with polycystic ovary syndrome: a community-based cohort study. Fertil Steril 2019; 112 (02) 353-361
    CrossrefPubMedGoogle Scholar
  • 8 Teede HJ, Misso ML, Costello MF. et al; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod 2018; 33 (09) 1602-1618
    CrossrefPubMedGoogle Scholar
  • 9 Tay CT, Teede HJ, Loxton D, Kulkarni J, Joham AE. Psychiatric comorbidities and adverse childhood experiences in women with self-reported polycystic ovary syndrome: an Australian population-based study. Psychoneuroendocrinology 2020; 116: 104678
    CrossrefPubMedGoogle Scholar
  • 10 Gilbert EW, Tay CT, Hiam DS, Teede HJ, Moran LJ. Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews. Clin Endocrinol (Oxf) 2018; 89 (06) 683-699
    CrossrefPubMedGoogle Scholar
  • 11 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Melbourne: Monash University; 2018
    Google Scholar
  • 12 Al Wattar BH, Fisher M, Bevington L. et al. Clinical practice guidelines on the diagnosis and management of polycystic ovary syndrome: a systematic review and quality assessment study. J Clin Endocrinol Metab 2021; 106 (08) 2436-2446
    CrossrefPubMedGoogle Scholar
  • 13 Peña AS, Metz M. What is adolescent polycystic ovary syndrome?. J Paediatr Child Health 2018; 54 (04) 351-355
    CrossrefPubMedGoogle Scholar
  • 14 Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1967; 12 (1, Pt 2): 77-126
    PubMedGoogle Scholar
  • 15 Widholm O, Kantero RL. A statistical analysis of the menstrual patterns of 8,000 Finnish girls and their mothers. Acta Obstet Gynecol Scand Suppl 1971; 14 (Suppl. 14) 14 , 1–36
    PubMedGoogle Scholar
  • 16 Apter D, Vihko R. Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J Clin Endocrinol Metab 1983; 57 (01) 82-86
    CrossrefPubMedGoogle Scholar
  • 17 Metcalf MG, Skidmore DS, Lowry GF, Mackenzie JA. Incidence of ovulation in the years after the menarche. J Endocrinol 1983; 97 (02) 213-219
    CrossrefPubMedGoogle Scholar
  • 18 Flug D, Largo RH, Prader A. Menstrual patterns in adolescent Swiss girls: a longitudinal study. Ann Hum Biol 1984; 11 (06) 495-508
    CrossrefPubMedGoogle Scholar
  • 19 van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Relationship of the menstrual cycle pattern in 14-17 year old adolescents with gynaecological age, body mass index and historical parameters. Hum Reprod 1998; 13 (08) 2252-2260
    CrossrefPubMedGoogle Scholar
  • 20 Legro RS, Lin HM, Demers LM, Lloyd T. Rapid maturation of the reproductive axis during perimenarche independent of body composition. J Clin Endocrinol Metab 2000; 85 (03) 1021-1025
    PubMedGoogle Scholar
  • 21 Gunn HM, Tsai MC, McRae A, Steinbeck KS. Menstrual patterns in the first gynecological year: a systematic review. J Pediatr Adolesc Gynecol 2018; 31 (06) 557-565.e6
    CrossrefPubMedGoogle Scholar
  • 22 Lemarchand-Béraud T, Zufferey MM, Reymond M, Rey I. Maturation of the hypothalamo-pituitary-ovarian axis in adolescent girls. J Clin Endocrinol Metab 1982; 54 (02) 241-246
    CrossrefPubMedGoogle Scholar
  • 23 Peña AS, Doherty DA, Atkinson HC, Hickey M, Norman RJ, Hart R. The majority of irregular menstrual cycles in adolescence are ovulatory: results of a prospective study. Arch Dis Child 2018; 103 (03) 235-239
    CrossrefPubMedGoogle Scholar
  • 24 Assens M, Dyre L, Henriksen LS. et al. Menstrual pattern, reproductive hormones, and transabdominal 3D ultrasound in 317 adolescent girls. J Clin Endocrinol Metab 2020; 105 (09) 105
    CrossrefPubMedGoogle Scholar
  • 25 Ibáñez L, Oberfield SE, Witchel S. et al. An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr 2017; 88 (06) 371-395
    CrossrefPubMedGoogle Scholar
  • 26 Teede HJ, Misso ML, Costello MF. et al; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018; 110 (03) 364-379
    CrossrefPubMedGoogle Scholar
  • 27 Peña AS, Witchel SF, Hoeger KM. et al. Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med 2020; 18 (01) 72
    CrossrefPubMedGoogle Scholar
  • 28 Witchel SF, Oberfield S, Rosenfield RL. et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr 2015; 83: 376-389
    CrossrefPubMedGoogle Scholar
  • 29 Kim BJ, Kim JY, Eun HC, Kwon OS, Kim MN, Ro BI. Androgenetic alopecia in adolescents: a report of 43 cases. J Dermatol 2006; 33 (10) 696-699
    CrossrefPubMedGoogle Scholar
  • 30 Lucky AW, Biro FM, Simbartl LA, Morrison JA, Sorg NW. Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study. J Pediatr 1997; 130 (01) 30-39
    CrossrefPubMedGoogle Scholar
  • 31 Eichenfield LF, Krakowski AC, Piggott C. et al; American Acne and Rosacea Society. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics 2013; 131 (Suppl. 03) S163-S186
    CrossrefPubMedGoogle Scholar
  • 32 Skroza N, Tolino E, Mambrin A. et al. Adult acne versus adolescent acne: a retrospective study of 1,167 patients. J Clin Aesthet Dermatol 2018; 11 (01) 21-25
    PubMedGoogle Scholar
  • 33 Silverberg JI, Silverberg NB. Epidemiology and extracutaneous comorbidities of severe acne in adolescence: a U.S. population-based study. Br J Dermatol 2014; 170 (05) 1136-1142
    CrossrefPubMedGoogle Scholar
  • 34 Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev 2000; 21 (04) 347-362
    PubMedGoogle Scholar
  • 35 Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually scoring hirsutism. Hum Reprod Update 2010; 16 (01) 51-64
    CrossrefPubMedGoogle Scholar
  • 36 Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-1447
    CrossrefPubMedGoogle Scholar
  • 37 Lucky AW, Biro FM, Daniels SR, Cedars MI, Khoury PR, Morrison JA. The prevalence of upper lip hair in black and white girls during puberty: a new standard. J Pediatr 2001; 138 (01) 134-136
    CrossrefPubMedGoogle Scholar
  • 38 Bili E, Dampala K, Iakovou I, Tsolakidis D, Giannakou A, Tarlatzis BC. The combination of ovarian volume and outline has better diagnostic accuracy than prostate-specific antigen (PSA) concentrations in women with polycystic ovarian syndrome (PCOs). Eur J Obstet Gynecol Reprod Biol 2014; 179: 32-35
    CrossrefPubMedGoogle Scholar
  • 39 Escobar-Morreale HF, Asunción M, Calvo RM, Sancho J, San Millán JL. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. Eur J Endocrinol 2001; 145 (05) 619-624
    CrossrefPubMedGoogle Scholar
  • 40 Koskinen P, Penttilä TA, Anttila L, Erkkola R, Irjala K. Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome. Fertil Steril 1996; 65 (03) 517-522
    CrossrefPubMedGoogle Scholar
  • 41 Rudnicka E, Radowicki S, Suchta K. Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome - a new insight. Gynecol Endocrinol 2016; 32 (11) 931-935
    CrossrefPubMedGoogle Scholar
  • 42 Stener-Victorin E, Holm G, Labrie F, Nilsson L, Janson PO, Ohlsson C. Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome?. J Clin Endocrinol Metab 2010; 95 (02) 810-819
    CrossrefPubMedGoogle Scholar
  • 43 Salameh WA, Redor-Goldman MM, Clarke NJ, Mathur R, Azziz R, Reitz RE. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria. Fertil Steril 2014; 101 (04) 1135-1141.e2
    CrossrefPubMedGoogle Scholar
  • 44 Villarroel C, López P, Merino PM, Iñiguez G, Sir-Petermann T, Codner E. Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents. Gynecol Endocrinol 2015; 31 (08) 625-629
    CrossrefPubMedGoogle Scholar
  • 45 Venturoli S, Porcu E, Fabbri R. et al. Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence. Pediatr Res 1995; 38 (06) 974-980
    CrossrefPubMedGoogle Scholar
  • 46 Kristensen SL, Ramlau-Hansen CH, Ernst E. et al. A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed?. Hum Reprod 2010; 25 (12) 3117-3122
    CrossrefPubMedGoogle Scholar
  • 47 Hickey M, Doherty DA, Atkinson H. et al. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum Reprod 2011; 26 (06) 1469-1477
    CrossrefPubMedGoogle Scholar
  • 48 Codner E, Villarroel C, Eyzaguirre FC. et al. Polycystic ovarian morphology in postmenarchal adolescents. Fertil Steril 2011; 95 (02) 702-6.e1 , 2
    CrossrefPubMedGoogle Scholar
  • 49 Radivojevic UD, Lazovic GB, Kravic-Stevovic TK. et al. Differences in anthropometric and ultrasonographic parameters between adolescent girls with regular and irregular menstrual cycles: a case-study of 835 cases. J Pediatr Adolesc Gynecol 2014; 27 (04) 227-231
    CrossrefPubMedGoogle Scholar
  • 50 Razzaghy-Azar M, Ghasemi F, Hallaji F, Ghasemi A, Ghasemi M. Sonographic measurement of uterus and ovaries in premenarcheal healthy girls between 6 and 13 years old: correlation with age and pubertal status. J Clin Ultrasound 2011; 39 (02) 64-73
    CrossrefPubMedGoogle Scholar
  • 51 Kelsey TW, Dodwell SK, Wilkinson AG. et al. Ovarian volume throughout life: a validated normative model. PLoS One 2013; 8 (09) e71465
    CrossrefPubMedGoogle Scholar
  • 52 Herter LD, Golendziner E, Flores JA, Becker Jr E, Spritzer PM. Ovarian and uterine sonography in healthy girls between 1 and 13 years old: correlation of findings with age and pubertal status. AJR Am J Roentgenol 2002; 178 (06) 1531-1536
    CrossrefPubMedGoogle Scholar
  • 53 Fulghesu AM, Canu E, Casula L, Melis F, Gambineri A. Polycystic ovarian morphology in normocyclic non-hyperandrogenic adolescents. J Pediatr Adolesc Gynecol 2021; 34 (05) 610-616
    CrossrefPubMedGoogle Scholar
  • 54 Chen Y, Yang D, Li L, Chen X. The role of ovarian volume as a diagnostic criterion for Chinese adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2008; 21 (06) 347-350
    CrossrefPubMedGoogle Scholar
  • 55 Villa P, Rossodivita A, Sagnella F. et al. Ovarian volume and gluco-insulinaemic markers in the diagnosis of PCOS during adolescence. Clin Endocrinol (Oxf) 2013; 78 (02) 285-290
    CrossrefPubMedGoogle Scholar
  • 56 Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM. Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab 2013; 98 (08) 3332-3340
    CrossrefPubMedGoogle Scholar
  • 57 Hart R, Doherty DA, Norman RJ. et al. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril 2010; 94 (03) 1118-1121
    CrossrefPubMedGoogle Scholar
  • 58 Sopher AB, Grigoriev G, Laura D. et al. Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents. J Pediatr Endocrinol Metab 2014; 27 (11-12): 1175-1179
    PubMedGoogle Scholar
  • 59 Tokmak A, Timur H, Aksoy RT, Çınar M, Yılmaz N. Is anti-Mullerian hormone a good diagnostic marker for adolescent and young adult patients with Polycystic ovary syndrome?. Turk J Obstet Gynecol 2015; 12 (04) 199-204
    CrossrefPubMedGoogle Scholar
  • 60 Yetim A, Yetim Ç, Baş F. et al. Anti-Müllerian hormone and inhibin-A, but not inhibin-B or insulin-like peptide-3, may be used as surrogates in the diagnosis of polycystic ovary syndrome in adolescents: preliminary results. J Clin Res Pediatr Endocrinol 2016; 8 (03) 288-297
    CrossrefPubMedGoogle Scholar
  • 61 Kim JY, Tfayli H, Michaliszyn SF, Lee S, Nasr A, Arslanian S. Anti-Müllerian hormone in obese adolescent girls with polycystic ovary syndrome. J Adolesc Health 2017; 60 (03) 333-339
    CrossrefPubMedGoogle Scholar
  • 62 Fernandez RC, Moore VM, Rumbold AR, Whitrow MJ, Avery JC, Davies MJ. Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years. Hum Reprod 2021; 36 (08) 2275-2284
    CrossrefPubMedGoogle Scholar
  • 63 Tay CT, Hart RJ, Hickey M. et al. Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood. BMC Med 2020; 18 (01) 389
    CrossrefPubMedGoogle Scholar
  • 64 March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25 (02) 544-551
    Google Scholar
  • 65 Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG 2006; 113 (10) 1148-1159
    CrossrefPubMedGoogle Scholar
  • 66 Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 2009; 92 (06) 1966-1982
    CrossrefPubMedGoogle Scholar
  • 67 Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352 (12) 1223-1236
    CrossrefPubMedGoogle Scholar
  • 68 Styne DM, Arslanian SA, Connor EL. et al. Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2017; 102 (03) 709-757
    CrossrefPubMedGoogle Scholar
  • 69 Vatopoulou A, Tziomalos K. Management of obesity in adolescents with polycystic ovary syndrome. Expert Opin Pharmacother 2020; 21 (02) 207-211
    CrossrefPubMedGoogle Scholar
  • 70 Christensen SB, Black MH, Smith N. et al. Prevalence of polycystic ovary syndrome in adolescents. Fertil Steril 2013; 100 (02) 470-477
    CrossrefPubMedGoogle Scholar
  • 71 Li L, Feng Q, Ye M, He Y, Yao A, Shi K. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis. J Obstet Gynaecol 2017; 37 (08) 1036-1047
    CrossrefPubMedGoogle Scholar
  • 72 Després JP. Abdominal obesity and the risk of coronary artery disease. Can J Cardiol 1992; 8 (06) 561-562
    PubMedGoogle Scholar
  • 73 Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol 2011; 4 (02) 45-51
    PubMedGoogle Scholar
  • 74 Teede HJ, Hutchison S, Zoungas S, Meyer C. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS. Endocrine 2006; 30 (01) 45-53
    CrossrefPubMedGoogle Scholar
  • 75 Hart R, Doherty DA, Mori T. et al. Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome. Fertil Steril 2011; 95 (07) 2347-2353 , 2353.e1
    CrossrefPubMedGoogle Scholar
  • 76 Stepto NK, Cassar S, Joham AE. et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod 2013; 28 (03) 777-784
    CrossrefPubMedGoogle Scholar
  • 77 Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41
    CrossrefPubMedGoogle Scholar
  • 78 Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22 (01) 141-146
    CrossrefPubMedGoogle Scholar
  • 79 Hudnut-Beumler J, Kaar JL, Taylor A. et al. Development of type 2 diabetes in adolescent girls with polycystic ovary syndrome and obesity. Pediatr Diabetes 2021; 22 (05) 699-706
    CrossrefPubMedGoogle Scholar
  • 80 Peña AS, Curran JA, Fuery M. et al. Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australasian Paediatric Endocrine Group guidelines. Med J Aust 2020; 213 (01) 30-43
    CrossrefPubMedGoogle Scholar
  • 81 Veltman-Verhulst SM, Boivin J, Eijkemans MJ, Fauser BJ. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update 2012; 18 (06) 638-651
    CrossrefPubMedGoogle Scholar
  • 82 Lee I, Cooney LG, Saini S, Sammel MD, Allison KC, Dokras A. Increased odds of disordered eating in polycystic ovary syndrome: a systematic review and meta-analysis. Eat Weight Disord 2019; 24 (05) 787-797
    CrossrefPubMedGoogle Scholar
  • 83 Harnod T, Chen W, Wang JH, Lin SZ, Ding DC. Association between depression risk and polycystic ovarian syndrome in young women: a retrospective nationwide population-based cohort study (1998-2013). Hum Reprod 2019; 34 (09) 1830-1837
    CrossrefPubMedGoogle Scholar
  • 84 Sari SA, Celik N, Uzun Cicek A. Body perception, self-esteem, and comorbid psychiatric disorders in adolescents diagnosed with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2020; 33 (06) 691-696
    CrossrefPubMedGoogle Scholar
  • 85 Thannickal A, Brutocao C, Alsawas M. et al. Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Clin Endocrinol (Oxf) 2020; 92 (04) 338-349
    CrossrefPubMedGoogle Scholar
  • 86 Almis H, Orhon FŞ, Bolu S, Almis BH. Self-concept, depression, and anxiety levels of adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2021; 34 (03) 311-316
    CrossrefPubMedGoogle Scholar
  • 87 Witchel SF, Oberfield SE, Peña AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc 2019; 3 (08) 1545-1573
    CrossrefPubMedGoogle Scholar
  • 88 Torres-Zegarra C, Sundararajan D, Benson J. et al. Care for adolescents with PCOS: development and prescribing patterns of a multidisciplinary clinic. J Pediatr Adolesc Gynecol 2021; 34 (05) 617-625
    CrossrefPubMedGoogle Scholar
  • 89 Trent ME, Rich M, Austin SB, Gordon CM. Quality of life in adolescent girls with polycystic ovary syndrome. Arch Pediatr Adolesc Med 2002; 156 (06) 556-560
    CrossrefPubMedGoogle Scholar
  • 90 Trent M, Austin SB, Rich M, Gordon CM. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr 2005; 5 (02) 107-111
    CrossrefPubMedGoogle Scholar
  • 91 Jones GL, Hall JM, Lashen HL, Balen AH, Ledger WL. Health-related quality of life among adolescents with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 2011; 40 (05) 577-588
    CrossrefPubMedGoogle Scholar
  • 92 Kaczmarek C, Haller DM, Yaron M. Health-related quality of life in adolescents and young adults with polycystic ovary syndrome: a systematic review. J Pediatr Adolesc Gynecol 2016; 29 (06) 551-557
    CrossrefPubMedGoogle Scholar
  • 93 Wilson NA, Peña AS. Quality of life in adolescent girls with polycystic ovary syndrome. J Paediatr Child Health 2020; 56 (09) 1351-1357
    CrossrefPubMedGoogle Scholar
  • 94 Geier LM, Bekx MT, Connor EL. Factors contributing to initial weight loss among adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2012; 25 (06) 367-370
    CrossrefPubMedGoogle Scholar
  • 95 Abdolahian S, Tehrani FR, Amiri M. et al. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Endocr Disord 2020; 20 (01) 71
    CrossrefPubMedGoogle Scholar
  • 96 Jakubowski KP, Black JJ, El Nokali NE. et al. Parents' readiness to change affects BMI reduction outcomes in adolescents with polycystic ovary syndrome. J Obes 2012; 2012: 298067
    CrossrefPubMedGoogle Scholar
  • 97 Hoeger K, Davidson K, Kochman L, Cherry T, Kopin L, Guzick DS. The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab 2008; 93 (11) 4299-4306
    CrossrefPubMedGoogle Scholar
  • 98 Ornstein RM, Copperman NM, Jacobson MS. Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2011; 24 (03) 161-165
    CrossrefPubMedGoogle Scholar
  • 99 Lass N, Kleber M, Winkel K, Wunsch R, Reinehr T. Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls. J Clin Endocrinol Metab 2011; 96 (11) 3533-3540
    CrossrefPubMedGoogle Scholar
  • 100 Marzouk TM, Sayed Ahmed WA. Effect of dietary weight loss on menstrual regularity in obese young adult women with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2015; 28 (06) 457-461
    CrossrefPubMedGoogle Scholar
  • 101 Wong JM, Gallagher M, Gooding H. et al. A randomized pilot study of dietary treatments for polycystic ovary syndrome in adolescents. Pediatr Obes 2016; 11 (03) 210-220
    CrossrefPubMedGoogle Scholar
  • 102 Patten RK, Boyle RA, Moholdt T. et al. Exercise interventions in polycystic ovary syndrome: a systematic review and meta-analysis. Front Physiol 2020; 11: 606
    CrossrefPubMedGoogle Scholar
  • 103 Chaput JP, Willumsen J, Bull F. et al. 2020 WHO guidelines on physical activity and sedentary behaviour for children and adolescents aged 5-17years: summary of the evidence. Int J Behav Nutr Phys Act 2020; 17 (01) 141
    CrossrefPubMedGoogle Scholar
  • 104 Al Khalifah RA, Florez ID, Dennis B, Thabane L, Bassilious E. Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis. Pediatrics 2016; 137 (05) 137
    CrossrefPubMedGoogle Scholar
  • 105 de Bastos M, Stegeman BH, Rosendaal FR. et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev 2014; (03) CD010813
    PubMedGoogle Scholar
  • 106 Chung JP, Yiu AK, Chung TK, Chan SS. A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome. J Pediatr Adolesc Gynecol 2014; 27 (03) 166-171
    CrossrefPubMedGoogle Scholar
  • 107 Martin KA, Chang RJ, Ehrmann DA. et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93 (04) 1105-1120
    CrossrefPubMedGoogle Scholar
  • 108 Young CC, Rew L, Monge M. Transition to self-management among adolescents with polycystic ovary syndrome: parent and adolescent perspectives. J Pediatr Nurs 2019; 47: 85-91
    CrossrefPubMedGoogle Scholar